阻断聚聚氨胺扩展受体的二分化,通过增加AR周转率来保护细胞免受DHT诱导的毒性
Allison Lisberg1, Yuhong Liu1, Diane E Merry1
1Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
The Journal of biological chemistry
|March 31, 2024
概括
脊柱和柱状肌肉缩 (SBMA) 是一种神经退行性疾病,没有治愈的方法. 阻断雄激素受体 (AR) 均质化减少AR聚合和毒性,为SBMA提供了潜在的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 脊柱和腹筋肌缩 (SBMA) 是一种进展性神经肌肉疾病.
- 它是由于androgen受体 (AR) 中的多重胺扩张引起的,导致AR错误折叠,聚合和运动神经元毒性.
- 目前对SBMA的治疗方法有限.
研究的目的:
- 为了研究雄激素受体 (AR) 均质化在SBMA病变发生中的作用.
- 探索AR同质化作为SBMA的潜在治疗标.
主要方法:
- 在SBMA模型中研究了AR的N/C相互作用和同质化.
- 利用细胞模型来评估阻断AR同质化对AR聚合和毒性的影响.
- 检查了AR降解路径.
主要成果:
- 在AR中聚氨胺扩张减少了N/C相互作用,但增加了5α-二氨 (DHT) 结合的AR的同位素.
- 阻断AR同质化减少了细胞模型中的AR聚合和毒性.
- 抑制同体化导致AR降解的增加,这表明存在保护机制.
结论:
- AR同位化是导致SBMA病理的一个关键机制.
- 阻断AR同质化代表了SBMA的一个新的治疗策略.
- 向AR同体化可能为SBMA治疗开发提供了一条新的途径.
相关概念视频
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
720
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
806
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
806


